Target Name: MIR6861
NCBI ID: G102465519
Review Report on MIR6861 Target / Biomarker Content of Review Report on MIR6861 Target / Biomarker
MIR6861
Other Name(s): MicroRNA 6861 | hsa-miR-6861-3p | hsa-miR-6861-5p | microRNA 6861 | hsa-mir-6861

MIR6861: A Potential Drug Target and Biomarker for Cancer and Stress-Related Diseases

MicroRNA (miRNA) 6861 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR6861 is a small molecule that can interact with the sirtuin RNA-protein complex, a protein that regulates DNA replication and cell growth. By interacting with this protein, MIR6861 has been shown to regulate cell proliferation and induce cell apoptosis, which is a natural response to harmful stimuli.

The sirtuin RNA-protein complex is a group of proteins that include hnRNPK, snRNA-protein complex 1 (SPC1), and SPC2. These proteins are highly conserved across various species and are involved in various cellular processes, including DNA replication, transcription, and stress response. hnRNPK is a key regulator of DNA replication and has been shown to play a role in cancer progression. SPC1 and SPC2 are involved in stress response and have been shown to contribute to various diseases, including cancer.

MIR6861 has been shown to interact with hnRNPK and SPC1, which suggests that it may be a drug target or biomarker for these diseases. One potential mechanism by which MIR6861 may interact with hnRNPK is through its ability to regulate cell proliferation. MIR6861 has been shown to inhibit hnRNPK-mediated cell proliferation and induce cell apoptosis. This suggests that MIR6861 may be an effective drug against cancer, as inhibiting cell proliferation is a key goal of cancer treatment.

MIR6861 has also been shown to interact with SPC1, which is involved in stress response. MIR6861 has been shown to regulate the activity of SPC1 and to play a role in stress response. This suggests that MIR6861 may be an effective biomarker for stress-related diseases, as regulation of stress response is a key aspect of these diseases.

In addition to its potential role as a drug target and biomarker, MIR6861 has also been shown to have potential therapeutic applications. For example, MIR6861 has been shown to be downregulated in various cancer types, including breast cancer and colon cancer. This suggests that targeting MIR6861 may be an effective way to treat these cancers. Additionally, MIR6861 has been shown to be involved in the regulation of cellular processes that are important for maintaining cellular homeostasis, such as cell adhesion and migration. This suggests that MIR6861 may be an effective drug target or biomarker for diseases that are characterized by cellular dysfunction and abnormal behavior.

In conclusion, MIR6861 is a small molecule that has been shown to interact with the sirtuin RNA-protein complex, which includes hnRNPK and SPC1. These interactions suggest that MIR6861 may be a drug target or biomarker for various diseases, including cancer and stress-related conditions. Further research is needed to fully understand the role of MIR6861 in these diseases and to develop effective treatments.

Protein Name: MicroRNA 6861

The "MIR6861 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6861 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802